
### [NCIT:C6451](http://purl.obolibrary.org/obo/NCIT_C6451)
**Label:** Thymic Lymphoma

**Subclasses:** [NCIT:C9280](http://purl.obolibrary.org/obo/NCIT_C9280) (Mediastinal (Thymic) Large B-Cell Lymphoma), [NCIT:C8878](http://purl.obolibrary.org/obo/NCIT_C8878) (Stage III Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8879](http://purl.obolibrary.org/obo/NCIT_C8879) (Stage IV Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8876](http://purl.obolibrary.org/obo/NCIT_C8876) (Stage I Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8877](http://purl.obolibrary.org/obo/NCIT_C8877) (Stage II Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8874](http://purl.obolibrary.org/obo/NCIT_C8874) (Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8875](http://purl.obolibrary.org/obo/NCIT_C8875) (Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma), 

**Class expressions from DL-Learner:**

- [UBERON:0003728](http://purl.obolibrary.org/obo/UBERON_0003728) (mediastinum) 55.56%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) 55.56%
- [NCIT:C45212](http://purl.obolibrary.org/obo/NCIT_C45212) (PDCD1LG2 Gene Overexpression) 55.56%
- [NCIT:C38329](http://purl.obolibrary.org/obo/NCIT_C38329) (Thymic B-Lymphocyte) 55.56%
- [NCIT:C36442](http://purl.obolibrary.org/obo/NCIT_C36442) (Clonal BCL2 Gene Rearrangement) 55.56%
- [NCIT:C13225](http://purl.obolibrary.org/obo/NCIT_C13225) (Chromosome 9) 55.56%
- [UBERON:0004177](http://purl.obolibrary.org/obo/UBERON_0004177) (hemopoietic organ) and [UBERON:0005058](http://purl.obolibrary.org/obo/UBERON_0005058) (hemolymphoid system gland) 55.56%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) and [UBERON:0004177](http://purl.obolibrary.org/obo/UBERON_0004177) (hemopoietic organ) 55.56%
- [UBERON:0002530](http://purl.obolibrary.org/obo/UBERON_0002530) (gland) and [UBERON:0004177](http://purl.obolibrary.org/obo/UBERON_0004177) (hemopoietic organ) 55.56%
- [UBERON:0002368](http://purl.obolibrary.org/obo/UBERON_0002368) (endocrine gland) and [UBERON:0004177](http://purl.obolibrary.org/obo/UBERON_0004177) (hemopoietic organ) 55.56%
- [UBERON:0000077](http://purl.obolibrary.org/obo/UBERON_0000077) (mixed endoderm/mesoderm-derived structure) and [UBERON:0004177](http://purl.obolibrary.org/obo/UBERON_0004177) (hemopoietic organ) 55.56%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and [NCIT:C36333](http://purl.obolibrary.org/obo/NCIT_C36333) (Clonal Gene Rearrangement) 55.56%
- [UBERON:0004177](http://purl.obolibrary.org/obo/UBERON_0004177) (hemopoietic organ) and [UBERON:0005057](http://purl.obolibrary.org/obo/UBERON_0005057) (immune organ) and [UBERON:0005058](http://purl.obolibrary.org/obo/UBERON_0005058) (hemolymphoid system gland) 55.56%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) and [UBERON:0004177](http://purl.obolibrary.org/obo/UBERON_0004177) (hemopoietic organ) and [UBERON:0005057](http://purl.obolibrary.org/obo/UBERON_0005057) (immune organ) 55.56%
- [UBERON:0002530](http://purl.obolibrary.org/obo/UBERON_0002530) (gland) and [UBERON:0004177](http://purl.obolibrary.org/obo/UBERON_0004177) (hemopoietic organ) and [UBERON:0005057](http://purl.obolibrary.org/obo/UBERON_0005057) (immune organ) 55.56%


